NCT02994511View on ClinicalTrials.gov

Cambridge Liquid Biopsy and Tumour Profiling Study for Patients on Experimental Therapeutics Trials

UnknownOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

December 8, 2014

Primary Completion Date

March 30, 2020

Study Completion Date

March 30, 2020

Conditions
Cancer
Trial Locations (1)

CB2 0QQ

RECRUITING

Cambridge University Hospitals NHS Foundation Trust, Cambridge

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

CCTU- Cancer Theme

OTHER